GSK R&D to Revenue
22.98%Fiscal year
Period ending:
GSK FY R&D/Revenue%
25.74%-2.76%
1986-06-302025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
GSK r&d to revenue history
R&D spending as percentage of revenue. The available annual fiscal periods series contains 41 observations from Jun 30, 1986 to Dec 31, 2025.
| Period ending | R&D to Revenue |
|---|---|
| 22.9834% | |
| 17.5198% | |
| 17.2942% | |
| 16.4916% | |
| 17.76% | |
| 13.1353% | |
| 12.5763% | |
| 11.8685% | |
| 12.8039% | |
| 12.4816% | |
| 14.2959% | |
| 14.4962% | |
| 12.9636% | |
| 13.1928% | |
| 13.4553% | |
| 15.1557% | |
| 14.0052% | |
| 14.7216% | |
| 14.3335% | |
| 14.8848% | |
| 14.4783% | |
| 14.5302% | |
| 13.0171% | |
| 13.6715% | |
| 12.4715% | |
| 13.972% | |
| 14.947% | |
| 14.5685% | |
| 14.386% | |
| 13.9192% | |
| 14.6806% | |
| 0% | |
| 15.1697% | |
| 14.9899% | |
| 14.5264% | |
| 13.9829% | |
| 13.2117% | |
| 12.5681% | |
| 11.1705% | |
| 8.5583% | |
| 7.9076% |
Compare r&d to revenue
All GSK financial metrics · GSK stock overview · How to interpret financial metrics